Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2009
11/05/2009WO2009132986A1 Imidazolidinone derivatives as 11b-hsd1 inhibitors
11/05/2009WO2009132979A1 4-trimethylammonio-butyrates as cpt2 inhibitors
11/05/2009WO2009132978A1 4-dimethylaminobutyric acid derivatives
11/05/2009WO2009132921A1 Spiro-indole derivatives for the treatment of parasitic diseases
11/05/2009WO2009132807A1 Polyphenolic extract
11/05/2009WO2009132774A1 New substituted indolin-2-one derivatives and their use as p39 mitogen-activated kinase inhibitors
11/05/2009WO2009132593A1 Quinoline compounds, pharmaceutical compositions, preparation methods and uses thereof
11/05/2009WO2009132478A1 Synthesis of timosaponin bii
11/05/2009WO2009132457A1 Fgf-9 and its use relating to blood vessels
11/05/2009WO2009132454A1 Di-t-butylphenyl piperazines as calcium channel blockers
11/05/2009WO2009132453A1 Cyclylamine derivatives as calcium channel blockers
11/05/2009WO2009132452A1 Diaryl-cyclylalkyl derivatives as calcium channel blockers
11/05/2009WO2009114729A3 Compounds, compositions and methods for treating lysosomal storage diseases and disorders
11/05/2009WO2009113108A3 Styrene maleic anhydride based formulation for male contraception and prostate cancer
11/05/2009WO2009113090A3 Process for preparing an oral formulation of an acid-sensitive benzimidazole drug
11/05/2009WO2009113051A3 Oral modified-release formulations containing thiazepines
11/05/2009WO2009112954A3 Processes for the preparation of bosentan and related compounds
11/05/2009WO2009112653A3 Cosmetic and/or dermatological composition
11/05/2009WO2009112361A3 Synbiotic mixture
11/05/2009WO2009111846A4 Mitochondrially delivered anti-cancer compounds
11/05/2009WO2009111565A3 Use of lipoxins to counteract the impact of anesthetic on inflammatory resolution
11/05/2009WO2009111218A3 Ccr5 antagonists as prophylactics for preventing hiv infection and methods of inhibiting transmission of same
11/05/2009WO2009111173A3 Local embolization via heating of thermosensitive polymers
11/05/2009WO2009111172A3 Local embolization using thermosensitive polymers
11/05/2009WO2009109869A3 Alcohol antimicrobial skin sanitizing compositions including cationic compatible thickeners
11/05/2009WO2009106991A3 Pyridazine derivatives and their use as therapeutic agents in the treatment of skin disorders
11/05/2009WO2009105641A3 Preventing and treating amyloid-beta deposition by stimulation of innate immunity
11/05/2009WO2009105534A3 Ophthalmic nsaids as adjuvants
11/05/2009WO2009105164A3 Blood substitute solution
11/05/2009WO2009104916A3 Pharmaceutical formulations for the treatment of cardiovascular diseases
11/05/2009WO2009104147A3 Azatricyclic antibiotic compounds
11/05/2009WO2009102497A3 Genetic regulation of host defense mechanisms by mucosal exposure to natural interferon alpha species
11/05/2009WO2009102496A3 Selective agonist of toll-like receptor 3
11/05/2009WO2009101497A3 Topical pharmaceutical combination comprising minoxidil and aminexil
11/05/2009WO2009100107A3 Alendronate formulations, method of making and method of use thereof
11/05/2009WO2009099890A3 Methods of treating skin with aromatic skin-active ingredients
11/05/2009WO2009092602A3 Anti-angiogenic compounds
11/05/2009WO2009091898A3 6-and 7-amino isoquinoline compounds and methods for making and using the same
11/05/2009WO2009090648A3 Use of antimicrobial polymers for re-sensitization of microorganisms upon emergence of resistance to anti-microbial agents
11/05/2009WO2009089453A9 Hydroxylated pyrimidyl cyclopentane as akt protein kinase inhibitor
11/05/2009WO2009085226A3 Inhibitors of cdc2-like kinases (clks) and methods of use thereof
11/05/2009WO2009084069A4 Ocular solution with organic lycopene
11/05/2009WO2009077844A3 Inhibitors of biofilm formation of gram-positive and gram-negative bacteria
11/05/2009WO2009077693A3 Compositions containing at least one naphthoic acid derivative, benzoyl peroxide and at least one film-forming agent
11/05/2009WO2009071480A3 Substituted dihydropteridin-6-one derivatives, process for their preparation and their use as kinase inhibitors
11/05/2009WO2009070244A3 Methods for inhibiting fascin
11/05/2009WO2009062914A3 Blood pressure lowering combination comprising ipp and/or vpp
11/05/2009WO2009061909A3 Wet granulation using a water sequestering agent
11/05/2009WO2009053842A3 Prevention of recurrence of urethral stricture after a conventional treatment
11/05/2009WO2009044011A3 Use of at least one oxime derivative of 3,5-seco-4-norcholestane as antioxidants
11/05/2009WO2009044010A3 Use of at least one oxime derivative of cholest-4-en-3-one as antioxidants
11/05/2009WO2009044009A3 Use of 4-azacholest-4-ene n-oxide or derivatives thereof as antioxidants
11/05/2009WO2009034433A3 3-azabicyclo [3.1.0] hexane derivatives as vanilloid receptor ligands
11/05/2009WO2009004480A3 Quetiapine salts and their polymorphs
11/05/2009WO2009002829A3 Tableted compositions containing atazanavir
11/05/2009WO2009002826A3 Tableted compositions containing atazanavir
11/05/2009WO2009002823A3 Tableted compositions containing atazanavir
11/05/2009WO2009002821A3 Tableted compositions containing atazanavir
11/05/2009WO2008157408A8 Use of prodrugs of gaba analogs, antispasticity agents, and prodrugs of gaba b receptor agonists for treating spasticity
11/05/2009WO2008148080A3 Pharmaceutical compositions of [5(s)-(2'-hydroxyethoxy)-20(s)-camptothecin]
11/05/2009WO2008147817A3 Coated hyaluronic acid particles
11/05/2009WO2008130261A9 Treatment of infections by carbon monoxide
11/05/2009WO2008127659A3 Anticancer combination of a dac inhibitor and a tyrosine kinase inhibitor
11/05/2009WO2008107197A3 Nutrient compositions
11/05/2009WO2008069608A8 Method for screening anti-cancer compounds inhibiting function of tm4sf5 and anti-cancer composition containing chalcone compounds
11/05/2009WO2008033999A8 Kinase inhibitors useful for the treatment of proliferative diseases
11/05/2009WO2007131232A8 Compositions and their uses directed to ptpr alpha
11/05/2009US20090275884 Use of nucleic acids with reduced pressure therapy
11/05/2009US20090275872 Fluid wound dressing comprising partially cured polyurethane
11/05/2009US20090275748 For example, 5-tert-Butyl-2-{2-[4-(1-methyl-piperidin-4-yl)-butoxy]-pyridin-4-yl}-1H-benzoimidazole; use in leukocyte recruitment inhibition, in modulating H4 receptor, and in treating conditions such as inflammation, H4 receptor-mediated conditions, and related conditions
11/05/2009US20090275669 Flavor and fragrance composition
11/05/2009US20090275667 Use of allicin as preservative, as disinfectant, as antimicrobial or as biocidal agent
11/05/2009US20090275666 Condensation products, method for their production and use thereof in medicaments, as disinfectants or as a tannin
11/05/2009US20090275665 Enhanced biological potential of greater than 99% pure form of 1, 7-bis(4-hydroxy-3-methoxyphenyl)-3,5-heptanedione over corresponding 95% pure form-therapeutic and agricultural applications thereof
11/05/2009US20090275664 Novel polyamine analog conjugates and quinone conjugates as therapies for cancers and prostate diseases
11/05/2009US20090275662 Injectable veterinary composition
11/05/2009US20090275661 Preparation of the formaurindicarboxylic acid base and its derivations and use
11/05/2009US20090275660 Stable parenteral formulations of tigecycline
11/05/2009US20090275659 Phenyl acetic acid derivatives as inflammation modulators
11/05/2009US20090275658 Method for Producing a Raw Oil from Mixtures of Micro-Organisms and Plants, Oil Produced According to Said Method and Specific Uses of the Thus Produced Oil and, Optionally, Additional Refined Oil
11/05/2009US20090275657 Fatty acid antimicrobial
11/05/2009US20090275656 Medicinal Compositions of Salts, Chelates and/or Free Acids of Alpha Hydroxyl Organic Acids and Related Processes and Methods
11/05/2009US20090275655 Pharmaceutical Gallium Compositions and Methods
11/05/2009US20090275654 Pharmaceutical Gallium Compositions and Methods
11/05/2009US20090275653 Polymorphic forms of ladostigil tartrate
11/05/2009US20090275651 Alcanoic Acid Amides Substituted by Saturated O-Heterocycles
11/05/2009US20090275650 3-Acyl coumarins, thiochromones and quinolones and therapeutic uses thereof
11/05/2009US20090275649 Compositions And Methods For Identifying Modulars Of TRPV2
11/05/2009US20090275648 Macrocyclic ghrelin receptor antagonists and inverse agonists and methods of using the same
11/05/2009US20090275647 Taxane derivative composition
11/05/2009US20090275646 Therapeutic compounds
11/05/2009US20090275645 Method to induce neovascular formation and tissue regeneration
11/05/2009US20090275644 Novel adaptor protein that binds to mammalian toll-like receptor 3 and gene thereof
11/05/2009US20090275643 Tryptophanyl-tRNA synthetase-derived polypeptides useful for the regulation of angiogenesis
11/05/2009US20090275641 RNAi-Mediated Inhibition of RHO Kinase for Treatment of Ocular Disorders
11/05/2009US20090275640 siRNA targeting inner centromere protein antigens (INCENP)
11/05/2009US20090275639 Usp47 inhibtors and methods to induce apoptosis
11/05/2009US20090275638 Compositions and Methods for Inhibiting Expression of XBP-1 Gene
11/05/2009US20090275637 Protein tyrosine phosphatase inhibitors
11/05/2009US20090275636 Picornavirus and uses thereof
1 ... 2512 2513 2514 2515 2516 2517 2518 2519 2520 2521 2522 2523 2524 2525 2526 2527 2528 2529 2530 2531 2532 ... 7860